<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/>Opportunities center on AI-enabled imaging, lab automation, advanced 3D and patient-derived cell models, CRO partnerships, and expanding global life sciences research.Dublin, Sept. 15, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- <a href="https://www.researchandmarkets.com/reports/4904407/high-content-screening-market-global-forecast?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=4k9tfw&amp;utm_campaign=2349757+-+High+Content+Screening+Market+Forecasts+Growth+from+%243.37B+(2026)+to+%246.58B+by+2032%2c+Profiling+Thermo+Fisher%2c+Danaher%2c+GE+HealthCare+%26+27+Other+Key+Players&amp;utm_exec=clshmsai" rel="nofollow" target="_blank" title="High Content Screening Market - Global Forecast 2026-2032">"High Content Screening Market - Global Forecast 2026-2032"</a> has been added to ResearchAndMarkets.com's offering. This market research report examines the global High Content Screening Market, projected to reach USD 3.37 billion in 2026 and USD 6.58 billion by 2032, representing a CAGR of 11.69%. It evaluates market growth, technological developments, regional adoption, strategic economic blocs, and competitive priorities shaping high-content screening (HCS). Market Overview HCS is evolving from a specialized imaging workflow into a core platform for drug discovery, toxicology, and cell biology. Combining automated microscopy, multiplexed fluorescent assays, plate handling, and quantitative image analysis, HCS enables researchers to measure cellular phenotype, morphology, localization, viability, and pathway activity at scale. Demand is supported by the need for greater early-discovery productivity, predictive in vitro models, and reproducible evidence for lead optimization. Pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations increasingly use HCS for phenotypic screening, disease modeling, target validation, and safety assessment. These insights support strategic planning by clarifying where technologies and applications are gaining commercial relevance. Transformative Market Shifts Three connected trends are reshaping the market: . Assay miniaturization that improves throughput and resource efficiency . Adoption of 3D spheroids, organoids, co-cultures, and patient-derived cell models . Integration of robotic liquid handling, incubators, confocal imaging, environmental controls, and data management These developments improve biological relevance and reproducibility while increasing requirements for image quality, assay standardization, metadata capture, and scalable microscopy data storage. Artificial Intelligence Impact Machine learning and deep learning are improving segmentation, feature extraction, cell classification, and phenotype recognition. AI-enabled analysis is especially valuable in complex assays where subtle morphological changes are difficult to identify with conventional rules-based methods. Applications extend to label-free analysis, quality control, hit selection, toxicity prediction, and mechanism-of-action studies. Organizations must also address model validation, bias, auditability, reproducibility, and regulatory expectations. Evaluating these considerations can strengthen risk mitigation and guide responsible investment in AI-enabled platforms. Regional Market Insights North America remains a leading market due to pharmaceutical R&amp;D, NIH-supported research, established CRO networks, and early adoption of AI-enabled microscopy. Europe benefits from academic-industry collaboration, research funding, advanced cell biology expertise, and regulatory interest in non-animal testing methods. Asia-Pacific is expanding through investment in biopharmaceutical R&amp;D, precision medicine, regenerative medicine, and laboratory automation, particularly in China, Japan, South Korea, India, Australia, and Singapore. Latin America is gaining traction through Brazil and Mexico. The Middle East is advancing through biotechnology investment and healthcare diversification, while Africa remains at an earlier stage, with activity concentrated in infectious disease research and international partnerships. Strategic Economic Bloc Insights ASEAN markets are strengthening biomedical research, clinical trial capacity, automation, and manufacturing connections. GCC countries are investing in precision medicine, translational research, and advanced diagnostic infrastructure. The European Union provides supportive funding and regulatory conditions for advanced cell models and digital research. BRICS markets offer scale through biotechnology policies, disease research, academic expansion, and CRO capabilities. G7 countries lead in platform innovation, pharmaceutical discovery spending, data standards, and AI-enabled imaging. Country-Level Adoption The United States leads through pharmaceutical pipelines, biotechnology investment, academic core facilities, and specialized CROs. Canada combines translational research with strong AI capabilities, while Brazil anchors Latin American activity. The United Kingdom, Germany, France, Italy, and Spain maintain strong biomedical research and microscopy capabilities. China is supported by large-scale biopharmaceutical investment and automation, while India benefits from generics expertise and CRO capacity. Japan leads in regenerative medicine and precision cell analysis, South Korea combines biotechnology investment with advanced infrastructure, and Australia contributes through oncology, immunology, neuroscience, and translational research. Strategic Priorities for Industry Leaders Organizations should prioritize interoperable platforms connecting imaging systems, liquid handlers, LIMS, electronic laboratory notebooks, and cloud-ready repositories. Open formats, validated analysis pipelines, strong metadata standards, and flexible assay support can reduce vendor lock-in. Investment in AI governance, assay validation, workforce training, and collaboration among biologists, data scientists, and automation engineers is also critical. The market assessment enables decision-makers to identify partnership, market entry, and technology investment opportunities while aligning expansion plans with regional readiness. Key Takeaways from This Report . The market is forecast to grow from USD 3.37 billion in 2026 to USD 6.58 billion by 2032. . Advanced cell models, laboratory automation, and AI-enabled image analysis are central growth drivers. . North America remains a leading hub, while Asia-Pacific offers substantial expansion potential. . Interoperability, reproducibility, data governance, and validated analytics are essential competitive priorities. . Regional and country-level insights reveal practical opportunities for investment, partnerships, and market expansion. Key Attributes: <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Report Attribute</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">Details</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">No. of Pages</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">191</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Forecast Period</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">2026 - 2032</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Estimated Market Value (USD) in 2026</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">$3.37 Billion</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Forecasted Market Value (USD) by 2032</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">$6.58 Billion</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Compound Annual Growth Rate</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">11.6%</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Regions Covered</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Global</td></tr></table> Key Topics Covered: 1. Preface 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Segmentation &amp; Coverage 1.4. Years Considered for the Study 1.5. Currency Considered for the Study 1.6. Language Considered for the Study 1.7. Key Stakeholders 2. Research Methodology 2.1. Introduction 2.2. Research Design 2.2.1. Primary Research 2.2.2. Secondary Research 2.3. Research Framework 2.3.1. Qualitative Analysis 2.3.2. Quantitative Analysis 2.4. Market Size Estimation 2.4.1. Top-Down Approach 2.4.2. Bottom-Up Approach 2.5. Data Triangulation 2.6. Research Outcomes 2.7. Research Assumptions 2.8. Research Limitations 3. Executive Summary 3.1. Introduction 3.2. CXO Perspective 3.3. New Revenue Opportunities 3.4. Next-Generation Business Models 3.5. Industry Roadmap 4. Market Overview 4.1. Introduction 4.2. Industry Ecosystem &amp; Value Chain Analysis 4.2.1. Supply-Side Analysis 4.2.2. Demand-Side Analysis 4.2.3. Stakeholder Analysis 4.3. Market Dynamics 4.3.1. Key Drivers 4.3.2. Key Restraints 4.3.3. Key Opportunities 4.3.4. Key Challenges 4.4. Porter's Five Forces Analysis 4.5. PESTLE Analysis 4.6. Market Outlook 4.6.1. Near-Term Market Outlook (0-2 Years) 4.6.2. Medium-Term Market Outlook (3-5 Years) 4.6.3. Long-Term Market Outlook (5-10 Years) 4.7. Go-to-Market Strategy 5. Market Insights 5.1. Consumer Insights &amp; End-User Perspective 5.2. Consumer Experience Benchmarking 5.3. Opportunity Mapping 5.4. Distribution Channel Analysis 5.5. Pricing Trend Analysis 5.6. Regulatory Compliance &amp; Standards Framework 5.7. ESG &amp; Sustainability Analysis 5.8. Disruption &amp; Risk Scenarios 5.9. Return on Investment &amp; Cost-Benefit Analysis 6. Cumulative Impact of Artificial Intelligence 2026 7. High Content Screening Market, by Product Type 7.1. Introduction 7.2. Consumables 7.2.1. Detection Probes 7.2.2. Microplates 7.2.3. Reagents &amp; Kits 7.3. Instruments 7.3.1. Automated Microscopes 7.3.2. High Throughput Systems 7.3.3. Imaging Stations 7.4. Services 7.4.1. Assay Development &amp; Optimization 7.4.2. Contract Screening 7.4.3. Data Science &amp; AI Model Development 7.5. Software 7.5.1. Image Analysis Software 7.5.2. Data Management 8. High Content Screening Market, by Technology 8.1. Introduction 8.2. Fixed-Cell Imaging 8.3. Imaging Flow Cytometry 8.4. Imaging-Based HCS 8.4.1. Confocal Imaging 8.4.2. Widefield Imaging 8.5. Label-Free Imaging 8.6. Live-Cell Imaging 9. High Content Screening Market, by Throughput 9.1. Introduction 9.2. High 9.3. Low 9.4. Medium 10. High Content Screening Market, by Plate Format 10.1. Introduction 10.2. 1536-Well 10.3. 384-Well 10.4. 96-Well 11. High Content Screening Market, by Application 11.1. Introduction 11.2. Drug Discovery 11.2.1. Hit Identification 11.2.2. Lead Optimization 11.3. Oncology Research 11.3.1. Apoptosis Assays 11.3.2. Cell Proliferation 11.4. Toxicology Screening 11.4.1. Cytotoxicity Testing 11.4.2. Genotoxicity Testing 12. High Content Screening Market, by End User 12.1. Introduction 12.2. Academic &amp; Research Institutes 12.3. Contract Research Organizations 12.4. Pharma &amp; Biotech Firms 13. High Content Screening Market, by Sales Channel 13.1. Introduction 13.2. Direct 13.3. Distributor 13.4. Online Sales 14. High Content Screening Market, by Delivery Mode 14.1. Introduction 14.2. Cloud-based HCS Software 14.3. On-premise HCS Platforms 15. High Content Screening Market, by Region 15.1. Introduction 15.2. Europe 15.3. Asia-Pacific 15.4. North America 15.5. Latin America 15.6. Middle East 15.7. Africa 16. High Content Screening Market, by Group 16.1. Introduction 16.2. NATO 16.3. G7 16.4. European Union 16.5. BRICS 16.6. ASEAN 16.7. GCC 17. High Content Screening Market, by Country 17.1. Introduction 17.2. China 17.3. United States 17.4. India 17.5. Germany 17.6. Japan 17.7. United Kingdom 17.8. France 17.9. Italy 17.10. Canada 17.11. Brazil 17.12. Spain 17.13. Mexico 17.14. Russia 17.15. Australia 17.16. South Korea 18. Competitive Landscape 18.1. Market Share Analysis, 2025 18.2. Market Concentration Analysis, 2025 18.2.1. Concentration Ratio (CR) 18.2.2. Herfindahl Hirschman Index (HHI) 18.3. Recent Developments &amp; Impact Analysis, 2025 18.4. Product Portfolio Analysis, 2025 18.5. Benchmarking Analysis, 2025 19. Company Profiles 19.1. Thermo Fisher Scientific Inc. 19.2. Danaher Corporation 19.3. GE HealthCare Technologies Inc. 19.4. Bio-Rad Laboratories, Inc 19.5. Becton, Dickinson and Company 19.6. Yokogawa Electric Corporation 19.7. Revvity, Inc. 19.8. Agilent Technologies, Inc. 19.9. Nikon Corporation 19.10. Hamamatsu Photonics K.K. 19.11. Olympus Corporation 19.12. Charles River Laboratories International, Inc. 19.13. Pharmaron Beijing Co., Ltd. 19.14. Sartorius AG 19.15. Miltenyi Biotec B.V. &amp; Co. KG 19.16. Carl Zeiss AG 19.17. Evident Corporation 19.18. Aligned Genetics, Inc. 19.19. Ardigen S.A. 19.20. Axxam S.p.A 19.21. Cell Signaling Technology, Inc. 19.22. Corning Incorporated 19.23. Creative Biolabs 19.24. Curia Global, Inc. 19.25. Evotec SE 19.26. Ncardia Services B.V. 19.27. Sonrai Analytics 19.28. SPT Labtech Ltd. 19.29. Tecan Group Ltd. 19.30. TissueGnostics GmbH 20. Key Experts For more information about this report visit <a href="https://www.researchandmarkets.com/reports/4904407/high-content-screening-market-global-forecast?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=4k9tfw&amp;utm_campaign=2349757+-+High+Content+Screening+Market+Forecasts+Growth+from+%243.37B+(2026)+to+%246.58B+by+2032%2c+Profiling+Thermo+Fisher%2c+Danaher%2c+GE+HealthCare+%26+27+Other+Key+Players&amp;utm_exec=clshmsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/h5cc98</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. <pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/ZTJhZjQ0MTMtMjFmYS00NzI3LTk0ZmItY2ZjYTUxM2FjNTgwLTEwMjY3MzctMjAyNi0wOS0xNS1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

High Content Screening Market Forecasts Growth from $3.37B (2026) to $6.58B by 2032, Profiling Thermo Fisher, Danaher, GE HealthCare & 27 Other Key Players

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn